Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
Neuregulin-1β (NRG-1) is an emerging biomarker of heart failure (HF). The mechanisms of its action in HF patients are yet to be investigated. Cardioprotective and anti-inflammatory effects of NRG-1 have been reported.Aim. To assess NRG-1 levels in HF patients and investigate the association betwee...
Saved in:
| Main Authors: | K. A. Zhbanov, E. Yu. Salakheeva, I. Ya. Sokolova, E. A. Zheleznykh, V. Yu. Zektser, E. V. Privalova, Yu. N. Belenkov, A. A. Shchendrygina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2022-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma Level’s of Neuregulin-1 in Healthy People
by: K. A. Zhbanov, et al.
Published: (2022-01-01) -
Biomarkers in assessing the vulnerability of atherosclerotic plaques: a narrative review
by: A. N. Kovalskaya, et al.
Published: (2023-07-01) -
Pathogenetic significance of transforming growth factor β1 in patients with colorectal cancer
by: A. V. Chetveryakov, et al.
Published: (2022-10-01) -
Serum levels of neuregulin-1 in patients with coronary artery disease: clinical and pathogenetic aspects
by: E. A. Zakharyan, et al.
Published: (2024-02-01) -
Effects of melatonin on peritoneal fibrosis induced by high glucose peritoneal dialysis in rats
by: XING Bei-bei, et al.
Published: (2016-01-01)